These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2084078)

  • 41. [Characteristics of clinical symptoms and course of systemic scleroderma depending on sex and age of onset].
    Volkov AV; Starovoĭtova MN; Guseva NG
    Ter Arkh; 2004; 76(5):7-11. PubMed ID: 15230123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
    Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
    Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic sclerosis in old age.
    Br Med J; 1979 Nov; 2(6201):1313-4. PubMed ID: 519428
    [No Abstract]   [Full Text] [Related]  

  • 44. [Parodontoplethysmography. A method of objective evaluation of the course of progressive scleroderma].
    Bäurle G; Niedermeier W; Hornstein OP; Hofmann M
    Hautarzt; 1979 Aug; 30(8):427-31. PubMed ID: 511548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of scleroderma spectrum disorders in Slovenia.
    Sipek Dolničar A; Rotar Z; Tomsič M
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):8-11. PubMed ID: 23190708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, serological, and immunogenetic studies of systemic sclerosis.
    Maddison PJ
    Rev Rhum Mal Osteoartic; 1991 May; 58(5):369-70. PubMed ID: 1905420
    [No Abstract]   [Full Text] [Related]  

  • 47. Systemic sclerosis: a critical digest of the recent literature.
    Barsotti S; Bellando Randone S; Guiducci S; Della Rossa A
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S194-205. PubMed ID: 25372802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High prevalence of activated protein C resistance in patients with systemic sclerosis.
    De Lucia D; De Blasio G; Belli A; Conte M; Renis V; Di Mauro C; Tortora V; Valentini G
    Int J Clin Lab Res; 1995; 25(4):226-7. PubMed ID: 8788553
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic sclerosis. The Watson Smith Lecture 1984.
    Rowell NR
    J R Coll Physicians Lond; 1985 Jan; 19(1):23-30. PubMed ID: 3973839
    [No Abstract]   [Full Text] [Related]  

  • 50. Nedd5, a novel autoantigen in systemic sclerosis: is it a marker of more severe disease?
    Riccieri V; Alessandri C; Germano V; Guiducci S; Rogai V; Colasanti T; Delunardo F; Margutti P; Ortona E; Cerinic MM; Valesini G
    Ann Rheum Dis; 2010 Jan; 69(1):314-5. PubMed ID: 20007624
    [No Abstract]   [Full Text] [Related]  

  • 51. Markers of disease activity in systemic sclerosis.
    Matucci-Cerinic M; Pignone A; Biagini M; Lotti T
    Clin Dermatol; 1994; 12(2):291-7. PubMed ID: 8076268
    [No Abstract]   [Full Text] [Related]  

  • 52. Metabolic Syndrome in Systemic Sclerosis Patients: Data from Clinical Practice.
    Atzeni F; Marino F; Cirillo M; Gerratana E; Salaffi F; Alciati A
    Isr Med Assoc J; 2021 Apr; 23(4):262-263. PubMed ID: 33899364
    [No Abstract]   [Full Text] [Related]  

  • 53. Correspondence reply to authors J A Vondenberg et: RE: Increased malignancies in systemic sclerosis (IJRD: IJRD-2021-0787).
    Rees MS; Frampton C; White DHN; Solanki KK
    Int J Rheum Dis; 2022 Jan; 25(1):93-94. PubMed ID: 34958177
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical and Autoimmune Profi le of Systemic Sclerosis Patients from a Tertiary Care Centre in Central India.
    Deb R; Nelson SS
    J Assoc Physicians India; 2020 Jan; 68(1):69. PubMed ID: 31979689
    [No Abstract]   [Full Text] [Related]  

  • 55. Retracted article: The clinical and laboratory features in Turkish systemic sclerosis patients: a single-center experience.
    Rheumatol Int; 2012 Apr; 32(4):1043. PubMed ID: 22202922
    [No Abstract]   [Full Text] [Related]  

  • 56. Multiple Sclerosis in India.
    Goyal V
    Ann Indian Acad Neurol; 2018; 21(2):95-97. PubMed ID: 30122832
    [No Abstract]   [Full Text] [Related]  

  • 57. Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.
    Yen EY; Singh DR; Singh RR
    Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1502-1510. PubMed ID: 32770721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Observational Cross-Sectional Study of Varied Clinical Manifestations of Connective Tissue Disorders and their Association with Antinuclear Antibodies in a Tertiary Care Center.
    Kadiru RA; Hegde SP; Shenoy MM
    Indian Dermatol Online J; 2019; 10(4):413-417. PubMed ID: 31334060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?
    Janardana R; Nair AM; Surin AK; Prakash JAJ; Gowri M; Danda D
    Clin Rheumatol; 2019 Nov; 38(11):3179-3187. PubMed ID: 31309339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary involvement in systemic sclerosis: A clinical profile.
    Deepa AS; Rachel RP; Ramchandran P; Devaraj U; Arnold SA; Shobha V; D'souza G
    Lung India; 2016; 33(2):144-7. PubMed ID: 27051100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.